Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-041319
Filing Date
2022-07-25
Accepted
2022-07-25 16:30:17
Documents
7
Period of Report
2022-07-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea163210-6k_canfitebio.htm 6-K 23332
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL GENERAL MEETING ea163210ex99-1_canfitebio.htm EX-99.1 74019
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S ANNUAL G ea163210ex99-2_canfitebio.htm EX-99.2 15984
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH ea163210ex99-3_canfitebio.htm EX-99.3 1417
5 GRAPHIC ex99-1_001.jpg GRAPHIC 4480
6 GRAPHIC ex99-3i.jpg GRAPHIC 118390
7 GRAPHIC ex99-3ii.jpg GRAPHIC 122543
  Complete submission text file 0001213900-22-041319.txt   454179
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 221103705
SIC: 2834 Pharmaceutical Preparations